Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

✍ Scribed by Naito, K; Takeshita, A; Shigeno, K; Nakamura, S; Fujisawa, S; Shinjo, K; Yoshida, H; Ohnishi, K; Mori, M; Terakawa, S

• Book ID: 110054626
• Publisher: Nature Publishing Group
• Year: 2000
• Tongue: English
• Weight: 504 KB
• Volume: 14
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2401851